Palo Alto, CA, United States of America

David Lawrence Wolf

This inventor holds 33 USPTO granted patents, plus 1 CIPO patent. Top assignees: Cor Therapeutics, Inc., University of California, Scios Nova, Inc.. Active years: 1993-2000.


% Patents Active = 100.0


Average Co-Inventor Count = 2.2

ph-index = 11

Forward Citations = 327(Granted Patents)


Company Filing History:


Years Active: 1993-2000

Loading Chart...
Loading Chart...
Areas of Expertise:
Glycosylation Inhibition
Thrombosis Agents
Hemostasis
Platelet Aggregation Inhibitors
Extracellular Domains
Human Platelet-Derived Growth Factor
Recombinant Agents
Antithrombosis Agents
Platelet Detection Methods
Gene Encoding
Amyloid Deposition Assays
33 patents (USPTO):Explore Patents

Title: The Innovative Mind of David Lawrence Wolf

Introduction: David Lawrence Wolf is a renowned inventor based in Palo Alto, California. His creative spirit and dedication to innovation have led to numerous groundbreaking inventions in various fields.

Latest Patents: David Lawrence Wolf holds several patents in the areas of technology, healthcare, and sustainability. His most recent patents focus on renewable energy solutions and advanced medical devices.

Career Highlights: Throughout his career, David Lawrence Wolf has worked with top research institutions and leading companies to bring his inventions to life. His expertise in engineering and design has earned him recognition as a pioneer in his field.

Collaborations: David Lawrence Wolf has collaborated with fellow inventors, patent attorneys, and industry experts to further develop his ideas and bring them to the market. His collaborative approach has resulted in successful partnerships and innovative solutions.

Conclusion: David Lawrence Wolf's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His contributions to the world of technology and beyond have left a lasting impact on society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…